EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

New Acetamide-Sulfonamide-Containing Scaffolds: Antiurease Activity Screening, Structure-Activity Relationship, Kinetics Mechanism, Molecular Docking, and MD Simulation Studies

Saghir Ahmad, Muhammad Abdul Qadir, Mahmood Ahmed iD, Muhammad Imran iD, Numan Yousaf iD, Tanveer A Wani iD, Seema Zargar iD, Ijaz Ali, Muhammad Muddassar

Molecules · 2023

DOI: 10.3390/molecules28145389 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Saghir Ahmad und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry, University of the Punjab, Lahore 54590, Pakistan. Hauptthemen laut MEDLINE: Flurbiprofen. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: King Saud University, Riyadh Saudi Arabia, King Saud University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The development of novel scaffolds that can increase the effectiveness, safety, and convenience of medication therapy using drug conjugates is a promising strategy. As a result, drug conjugates are an active area of research and development in medicinal chemistry. This research demonstrates acetamide–sulfonamide scaffold preparation after conjugation of ibuprofen and flurbiprofen with sulfa drugs, and these scaffolds were then screened for urease inhibition. The newly designed conjugates were confirmed by spectroscopic techniques such as IR, 1HNMR, 13CNMR, and elemental analysis. Ibuprofen conjugated with sulfathiazole, flurbiprofen conjugated with sulfadiazine, and sulfamethoxazole were found to be potent and demonstrated a competitive mode of urease inhibition, with IC50 (µM) values of 9.95 ± 0.14, 16.74 ± 0.23, and 13.39 ± 0.11, respectively, and urease inhibition of 90.6, 84.1, and 86.1% respectively. Ibuprofen conjugated with sulfanilamide, sulfamerazine, and sulfacetamide, whereas flurbiprofen conjugated with sulfamerazine, and sulfacetamide exhibited a mixed mode of urease inhibition. Moreover, through molecular docking experiments, the urease receptor-binding mechanisms of competitive inhibitors were anticipated, and stability analysis through MD simulations showed that these compounds made stable complexes with the respective targets and that no conformational changes occurred during the simulation. The findings demonstrate that conjugates of approved therapeutic molecules may result in the development of novel classes of pharmacological agents for the treatment of various pathological conditions involving the urease enzyme.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FlurbiprofenMolecular Docking SimulationIbuprofenEnzyme InhibitorsSulfacetamideKineticsUreaseSulfamerazineCanavaliaStructure-Activity RelationshipSulfanilamideSulfonamidesMolecular Structure

Stichwörter der Autor:innen

NSAIDsdrug likenessin silico studieskinetics studiessulfonamidesurease

Substanzen

FlurbiprofenIbuprofenEnzyme InhibitorsSulfacetamideUreaseSulfamerazineSulfanilamideSulfonamides

Autor:innen und Institutionen

  • School of Chemistry, University of the Punjab, Lahore 54590, Pakistan.
  • Department of Microbiology, Immunology and Cancer Biology, School of Medicine, University of Virginia, Charlottesville, VA 22904, USA.
  • Department of Chemistry, Division of Science and Technology, University of Education, College Road, Lahore 54770, Pakistan.
  • Kauser Abdulla Malik School of Life Sciences, Forman Christian College (A Chartered University), Lahore 54600, Pakistan.
  • Department of Biosciences, COMSATS University Islamabad, Park Road, Islamabad 45550, Pakistan.
  • Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia.

ORCID-Profile: Mahmood Ahmed, Muhammad Imran, Numan Yousaf, Tanveer A Wani, Seema Zargar

Förderung

  • King Saud University, Riyadh Saudi Arabia
  • King Saud University

Zitieren

APA

Ahmad, S., Abdul Qadir, M., Ahmed, M., Imran, M., Yousaf, N., Wani, T. A., Zargar, S., Ali, I., & Muddassar, M. (2023). New Acetamide-Sulfonamide-Containing Scaffolds: Antiurease Activity Screening, Structure-Activity Relationship, Kinetics Mechanism, Molecular Docking, and MD Simulation Studies. Molecules. https://doi.org/10.3390/molecules28145389

Vancouver

Ahmad S, Abdul Qadir M, Ahmed M, Imran M, Yousaf N, Wani TA, et al. New Acetamide-Sulfonamide-Containing Scaffolds: Antiurease Activity Screening, Structure-Activity Relationship, Kinetics Mechanism, Molecular Docking, and MD Simulation Studies. Molecules. 2023. doi:10.3390/molecules28145389

BibTeX
@article{Ahmad2023,
  author = {Ahmad, Saghir and Abdul Qadir, Muhammad and Ahmed, Mahmood and Imran, Muhammad and Yousaf, Numan and Wani, Tanveer A and Zargar, Seema and Ali, Ijaz and Muddassar, Muhammad},
  title = {New Acetamide-Sulfonamide-Containing Scaffolds: Antiurease Activity Screening, Structure-Activity Relationship, Kinetics Mechanism, Molecular Docking, and MD Simulation Studies},
  journal = {Molecules},
  year = {2023},
  doi = {10.3390/molecules28145389}
}
Kostenlos starten →